Neoadjuvant Chemoimmunotherapy for Initially Resectable Non-Small Cell Lung Cancer: Queen's Gambit or CheckMate?
Int J Radiat Oncol Biol Phys
.
2024 Mar 1;118(3):585-586.
doi: 10.1016/j.ijrobp.2023.11.016.
Authors
Alyssa Farley
1
,
Bailey Nelson
2
Affiliations
1
Department of Radiation Oncology, University of Cincinnati, Cincinnati, Ohio.
2
Department of Radiation Oncology, University of Cincinnati, Cincinnati, Ohio. Electronic address: nelsonb4@ucmail.uc.edu.
PMID:
38340763
DOI:
10.1016/j.ijrobp.2023.11.016
No abstract available
Publication types
Editorial
MeSH terms
Carcinoma, Non-Small-Cell Lung* / therapy
Humans
Lung Neoplasms* / therapy
Neoadjuvant Therapy